Big pharma, Biotech, Partnering

Vivaldi Biosciences biotech partners with Baxter for influenza vaccine assets

Posted on 11 October 2013

Tags: , , , ,

Vivaldi Biosciences has acquired from Baxter Healthcare research and development assets, including intellectual property, clinical data, know-how and materials, for LAIVs in which the gene for influenza nonstructural protein 1 has been fully deleted.

NS1 is a multifunctional virulence factor of influenza.

In a Phase 1 clinical study of a delta-NS1 LAIV for highly pathogenic avian influenza A(H5N1) (“bird flu”), two Phase 1 studies of delta-NS1 LAIVs for seasonal H1N1 influenza strains, and a Phase 1/2 study of a trivalent delta-NS1 LAIV for seasonal influenza, the candidate vaccines were well-tolerated and generated positive immunogenicity data in a dose-dependent manner.

The vaccines evaluated in the four clinical studies were produced using Vero cell substrate technologies.

The acquired assets complement and substantially broaden Vivaldi’s LAIV platform and product development opportunities in pandemic preparedness and seasonal influenza.

For further deal information visit Current Agreements (subscription required)

Related

Read: Big pharma deal news - latest deal news for top 50 pharma / big pharma companies

Report: Vaccine Partnering Terms and Agreements

Report: Partnering Deals and Alliances with Baxter Healthcare

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

Print Friendly, PDF & Email

Leave a Reply